Summary
IN a review of eleven patients with aspergilloma attending St. Vincent’s Hospital between 1973 and 1984 sarcoid osis was the commonest predisposing disease (six patients) whereas cavitary tuberculosis, previously the most frequently associated condition, was present in only two patients. All patients had a combined restrictive-obstructive pulmonary deficit with mean values for FVC, FEV, and DLCO being 49%, 35% and 46% of predicted respectively. Life threatening haemoptysis was the most significant complication, occurring in six of eleven patients. In only two of these patients was lung function sufficiently adequate to permit surgical resection and both are alive 5 and 9 years respectively following the procedure. Four patients precluded from surgery because of prohibitive lung function had emergency bronchial arteriography performed with a vitw to arterial embolisation. This was successfully achieved in three patients with prompt cessation of active major haemoptysis, but could not be performed in a fourth because of an arterial anomaly. However there were no long term survivors in this latter non-surgical group. Finally, in five untreated patients observed over a mean period of three years, no major complications developed, despite enlargement of the fungus ball in three individuals. This study demonstrates a changing pattern of underlying disease in patients with aspergilloma and illutrates the usefulness of emergency arterial embolisation in the short term management of life threatening haemoptysis.
Similar content being viewed by others
References
Benjamin, J. J., Koerner, S. K., Grunwald, R. P., Fell, S. C. 1971. Bilateral resections for aspergilloma. Chest 60, 107–109.
British Tuberculosis Association. 1970. Report from Research Committee. Tubercle 51, 227–245.
De Buitleir, M., FitzGerald, M. X. 1982. The changing profile of tuberculosis in a general teaching hospital—a five-year experience. Irish Med. J. 75, 390–399.
De Remee, R. A., Anderson, H. A. 1974. Sarcoidosis. A correlation of dyspnoea with roentgenographic stage and pulmonary function changes. Mayo Clin. Proc. 49, 743–745.
Editorial. 1971. Pulmonary aspergillosis. Br. Med. J. 2, 124.
Fellows, K. E., Khaw, K. T., Schuster, S., Shwachman, H. 1979. Bronchial artery embolisation in cystic fibrosis: technique and long-term results. J. Pediatr. 95, 959–963.
Fougner, A. K., Gjore, A. 1958. Aspergillom ved er tilfelle av sarcoidosis Boeck in lungene (Pulmonary aspergilloma in a case of Boeck’s sarcoidosis). Nord Med. 59, 303–305.
Garvey, J., Crastnopol, P., Weisz, D., Khan, F. 1977. Surgical treatment of pulmonary aspergilloma. rJ. Thor. Cardiovasc. Surg. 74(4), 542–7.
Hargis, J. L., Bone, R. C., Stewart, J., Bector, N., Hiller, F. C. 1980. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am. J. Med. 68, 389–394.
Irwin, A. 1966. Radiology of the aspergilloma. Clin. Rad. 18, 432–438.
Israel, H. L., Leuchner, G. S., Atkinson, G. W. 1982. Sarcoidosis and aspergilloma. Chest 4, 430–432.
Israel, H. L., Ostrow, M. A. 1969. Sarcoidosis and aspergilloma. Am. J. Mied. 47, 243–250.
Jewkes, J., Ray, P. H., Paneth, M., Citron, K. M. 1983. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 38, 572–578.
Joynson, D. H. M. 1977. Pulmonory aspergilloma. Br. J. Clin. Pract. 31, 207–216.
Kaplan, J., Johns, C. H. 1979. Mycetomas in pulmonary sarcoidosis: non-surgical management. Johns Hopkins Med. J. 145, 157–161.
Kilman, H. W., Changwoo, A., Andrews, N. C., Klassen, K. 1969. Surgery for pulmonary aspergillosis, J. Thor. Cardiovasc. Surg. 57, 642–7.
Libshitz, H. I., Atkinson, G. W., Israel, H. L. 1974. Pleural thickening as a manifestation of aspergillus superinfection. Amer. J. Rad. 120, 90.
Logan, J. 1964. Prevalence of sarcoidosis in the Irish Republic. Acta Med. Scand. 425, Suppl. 126.
McCartney, J. M. 1964. Pulmonary aspergillosis. A review and description of three new cases. Thorax 19, 287–97.
MacErlean, D. P., Gray, B. J., FitzGerald, M. X. 1979. Bronchial artery embolisation in the control of massive haemoptysis. Br. J. Rad. 52, 558–561.
Manning, L. K., Robertson, L. 1950. A case of aspergillosis treated with nystatin. Br. Med. J. i, 345.
Rafferty, P., Beverley, A. B., Beverley, A. B., Grant, I. W. 1983. What happens to patients with pumonary aspergilloma? Analysis of 23 cases. Thorax 579–83.
Remy, J., Arnaud, F., Fardou, J., Giraud, R., Voisin, C. 1977. Treatment of haemoptysis by embolisation of the bronchial arteries. Radiology 122, 33–37.
Saliba, A., Pacini, L., Beatty, P. A. 1961. Intracavitary fungus balls in pulmonary aspergillosis. Br. J. Dis. Chest. 55, 65–71.
Soltanzadeh, H., Wychulis, A. R., Rarrokh, S., Balanowski, P. J., Neville, W. E. 1977. Surgical treatment of pulmonary aspergilloma. Ann. Surg. 186, 13–16.
Varkey, B. M., Rose, H. D. 1976. Pulmonary aspergilloma—a rational approach to treatment. Am. J. Med. 61, 626–32.
Wollshlager, M. D., Khan, F. 1984. Aspergillomas complicating sarcoidosis: a prospective study in 100 patients. Chest 86, 585–588.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nolan, M.T., Long, J.P., MacErlean, D.P. et al. Aspergillomas and lung fibrosis — a review of cases in a general hospital. I.J.M.S. 154, 336–342 (1985). https://doi.org/10.1007/BF02937178
Issue Date:
DOI: https://doi.org/10.1007/BF02937178